PPARβ and PDK1 in Ovarian Cancer
Author Information
Author(s): Ahmed N, Riley C, Quinn M A
Primary Institution: Royal Women's Hospital, Melbourne, Victoria, Australia
Hypothesis
The expression of PPARβ and PDK1 will change with the progression of ovarian carcinoma.
Conclusion
The study found that PPARβ expression decreases in high-grade ovarian tumors, while PDK1 expression increases, suggesting PDK1's role in tumor progression.
Supporting Evidence
- Normal ovaries showed PPARβ staining localized in the epithelium and stroma.
- Approximately 20% of grades 2 and 3 tumors lacked PPARβ staining.
- All borderline and malignant ovarian tumors showed positive PDK1 staining.
Takeaway
This study looked at two proteins, PPARβ and PDK1, in ovarian tumors. It found that PPARβ is less in more serious tumors, while PDK1 is more, which might help the tumors grow.
Methodology
Immunohistochemical analysis was performed on ovarian tissues to assess the expression of PPARβ and PDK1.
Potential Biases
Potential bias in histopathological diagnosis as it was determined by two staff pathologists.
Limitations
The study had a small sample size for some tumor grades and relied on archival tissues.
Participant Demographics
Mean age of healthy volunteers was 51 years; women with benign tumors was 61 years; women with cancer was 60 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website